Positron emission tomography in cancer of the head and neck

被引：18
作者：
Hain, SF [1 ]
机构：
[1] UCH NHS Trust & Charing Cross Hosp, Hammersmith Hosp NHS Trust, Middlesex Hosp, Inst Nucl Med, London W1T 3AA, England
来源：
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY | 2005年 / 43卷 / 01期
关键词：
squamous cell; carcinoma; FDG; PET; head and neck cancer;
D O I：
10.1016/j.bjoms.2004.09.006
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
The use of positron emission tomography (PET) has increased in oncology and in the assessment of head and neck tumours, where it is most useful for recurrent disease. It has good sensitivity and specificity for diagnosis and staging but is generally not necessary except in difficult cases. Quantitative measures of uptake on PET at diagnosis and after treatment do seem to have prognostic value independent of other information about the tumour and so PET may influence management. It also has a rote in the identification of an unknown primary site and of synchronous primaries and metastases (often missed by other imaging). Fusion imaging with magnetic resonance (MRI) or computed tomography (CT) adds a new dimension with improved value for each technique. (C) 2004 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：1 / 6
页数：6
相关论文
共 46 条
[11]  
FRIEDMAN M, 1984, ARCH OTOLARYNGOL, V110, P443
[12]   Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity [J].
Goerres, GW ;
Schmid, DT ;
Grätz, KW ;
von Schulthess, GK ;
Eyrich, GK .
ORAL ONCOLOGY, 2003, 39 (06) :547-551
[13]   The clinical impact of 18F-FDG gamma PET in patients with recurrent well differentiated thyroid carcinoma [J].
Goshen, E ;
Cohen, O ;
Rotenberg, G ;
Oksman, Y ;
Karasik, A ;
Zwas, ST .
NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (09) :959-961
[14]  
Greven KM, 1997, CANCER J SCI AM, V3, P353
[15]   FDG-PET. A possible prognostic factor in head and neck cancer [J].
Halfpenny, W ;
Hain, SF ;
Biassoni, L ;
Maisey, MN ;
Sherman, JA ;
McGurk, M .
BRITISH JOURNAL OF CANCER, 2002, 86 (04) :512-516
[16]  
Hollenbeak CS, 2001, CANCER-AM CANCER SOC, V92, P2341, DOI 10.1002/1097-0142(20011101)92:9<2341::AID-CNCR1581>3.0.CO
[17]  
2-8
[18]   A new approach to pre-treatment assessment of the N0 neck in oral squamous cell carcinoma:: the role of sentinel node biopsy and positron emission tomography [J].
Hyde, NC ;
Prvulovich, E ;
Newman, L ;
Waddington, WA ;
Visvikis, D ;
Ell, P .
ORAL ONCOLOGY, 2003, 39 (04) :350-360
[19]   2(18F)-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation [J].
Jungehülsing, M ;
Scheidhauer, K ;
Damm, M ;
Pietrzyk, U ;
Eckel, H ;
Schicha, H ;
Stennert, E .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 123 (03) :294-301
[20]   SALIVARY-GLAND TUMORS - PRETHERAPY EVALUATION WITH PET [J].
KEYES, JW ;
HARKNESS, BA ;
GREVEN, KM ;
WILLIAMS, DW ;
WATSON, NE ;
MCGUIRT, WF .
RADIOLOGY, 1994, 192 (01) :99-102
12345